ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
Ozjin
|
81 |
21K |
4 |
20/03/20 |
20/03/20 |
ASX - By Stock
|
81
|
21K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4D, Half Year Accounts and Presentation
|
|
Ozjin
|
78 |
104K |
11 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
78
|
104K
|
11
|
|
ASX - By Stock
|
AN1 |
Re:
midkine and Covid-19
|
|
Ozjin
|
4 |
2.2K |
3 |
10/03/20 |
10/03/20 |
ASX - By Stock
|
4
|
2.2K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4D, Half Year Accounts and Presentation
|
|
Ozjin
|
78 |
104K |
3 |
10/03/20 |
10/03/20 |
ASX - By Stock
|
78
|
104K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4D, Half Year Accounts and Presentation
|
|
Ozjin
|
78 |
104K |
3 |
10/03/20 |
10/03/20 |
ASX - By Stock
|
78
|
104K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4D, Half Year Accounts and Presentation
|
|
Ozjin
|
78 |
104K |
2 |
10/03/20 |
10/03/20 |
ASX - By Stock
|
78
|
104K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Evolis Patent to be Granted in China
|
|
Ozjin
|
40 |
18K |
6 |
13/02/20 |
13/02/20 |
ASX - By Stock
|
40
|
18K
|
6
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Evolis Patent to be Granted in China
|
|
Ozjin
|
40 |
18K |
0 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
40
|
18K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Evolis Patent to be Granted in China
|
|
Ozjin
|
40 |
18K |
6 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
40
|
18K
|
6
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Notes to Appendix 4C
|
|
Ozjin
|
73 |
22K |
5 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
73
|
22K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Notes to Appendix 4C
|
|
Ozjin
|
73 |
22K |
1 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
73
|
22K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Notes to Appendix 4C
|
|
Ozjin
|
73 |
22K |
2 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
73
|
22K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Notes to Appendix 4C
|
|
Ozjin
|
73 |
22K |
1 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
73
|
22K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Notes to Appendix 4C
|
|
Ozjin
|
73 |
22K |
0 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
73
|
22K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Notes to Appendix 4C
|
|
Ozjin
|
73 |
22K |
1 |
30/01/20 |
30/01/20 |
ASX - By Stock
|
73
|
22K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
market re-rate
|
|
Ozjin
|
422 |
178K |
0 |
25/01/20 |
25/01/20 |
ASX - By Stock
|
422
|
178K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
market re-rate
|
|
Ozjin
|
422 |
178K |
1 |
25/01/20 |
25/01/20 |
ASX - By Stock
|
422
|
178K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Key Midkine Antibody Patents Granted in the US and Europe
|
|
Ozjin
|
10 |
7.4K |
7 |
06/01/20 |
06/01/20 |
ASX - By Stock
|
10
|
7.4K
|
7
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change in substantial holding
|
|
Ozjin
|
64 |
22K |
4 |
22/12/19 |
22/12/19 |
ASX - By Stock
|
64
|
22K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change in substantial holding
|
|
Ozjin
|
64 |
22K |
1 |
22/12/19 |
22/12/19 |
ASX - By Stock
|
64
|
22K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change in substantial holding
|
|
Ozjin
|
64 |
22K |
2 |
22/12/19 |
22/12/19 |
ASX - By Stock
|
64
|
22K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change in substantial holding
|
|
Ozjin
|
64 |
22K |
4 |
21/12/19 |
21/12/19 |
ASX - By Stock
|
64
|
22K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change in substantial holding
|
|
Ozjin
|
64 |
22K |
3 |
20/12/19 |
20/12/19 |
ASX - By Stock
|
64
|
22K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
market re-rate
|
|
Ozjin
|
422 |
178K |
11 |
21/11/19 |
21/11/19 |
ASX - By Stock
|
422
|
178K
|
11
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs Trading Agreement With API/Priceline
|
|
Ozjin
|
20 |
11K |
11 |
21/11/19 |
21/11/19 |
ASX - By Stock
|
20
|
11K
|
11
|
|
ASX - By Stock
|
AN1 |
Re:
market re-rate
|
|
Ozjin
|
422 |
178K |
10 |
25/10/19 |
25/10/19 |
ASX - By Stock
|
422
|
178K
|
10
|
|
ASX - By Stock
|
AN1 |
Re:
Evolis Dry Shampoo
|
|
Ozjin
|
54 |
20K |
4 |
22/10/19 |
22/10/19 |
ASX - By Stock
|
54
|
20K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
Ozjin
|
40 |
11K |
4 |
10/10/19 |
10/10/19 |
ASX - By Stock
|
40
|
11K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
Ozjin
|
40 |
11K |
2 |
10/10/19 |
10/10/19 |
ASX - By Stock
|
40
|
11K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Trading Halt
|
|
Ozjin
|
40 |
11K |
2 |
10/10/19 |
10/10/19 |
ASX - By Stock
|
40
|
11K
|
2
|
|
ASX - By Stock
|
CE1 |
Re:
Ann: Trading Halt
|
|
Ozjin
|
7 |
3.1K |
2 |
22/05/19 |
22/05/19 |
ASX - By Stock
|
7
|
3.1K
|
2
|
|
ASX - By Stock
|
WZR |
Re:
29c Base Case & $1.51 upside Valuation
|
|
Ozjin
|
408 |
141K |
3 |
21/05/19 |
21/05/19 |
ASX - By Stock
|
408
|
141K
|
3
|
|
ASX - By Stock
|
WZR |
Re:
29c Base Case & $1.51 upside Valuation
|
|
Ozjin
|
408 |
141K |
1 |
20/05/19 |
20/05/19 |
ASX - By Stock
|
408
|
141K
|
1
|
|
ASX - By Stock
|
WZR |
Re:
29c Base Case & $1.51 upside Valuation
|
|
Ozjin
|
408 |
141K |
0 |
20/05/19 |
20/05/19 |
ASX - By Stock
|
408
|
141K
|
0
|
|
ASX - By Stock
|
CE1 |
Re:
Ann: Quarterly Activities Report
|
|
Ozjin
|
25 |
5.8K |
0 |
25/04/19 |
25/04/19 |
ASX - By Stock
|
25
|
5.8K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change of Director's Interest Notice - Halasz
|
|
Ozjin
|
37 |
10K |
2 |
18/04/19 |
18/04/19 |
ASX - By Stock
|
37
|
10K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Updated - top 20 holders
|
|
Ozjin
|
31 |
10K |
4 |
16/04/19 |
16/04/19 |
ASX - By Stock
|
31
|
10K
|
4
|
|
ASX - By Stock
|
CE1 |
Re:
Ann: Calima 2 Flowing Gas and Light Oil
|
|
Ozjin
|
58 |
16K |
5 |
23/03/19 |
23/03/19 |
ASX - By Stock
|
58
|
16K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Fillerina
|
|
Ozjin
|
33 |
10K |
0 |
08/03/19 |
08/03/19 |
ASX - By Stock
|
33
|
10K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Fillerina
|
|
Ozjin
|
33 |
10K |
1 |
08/03/19 |
08/03/19 |
ASX - By Stock
|
33
|
10K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid to Commence Selling of Evolis into Chinese Market
|
|
Ozjin
|
101 |
42K |
7 |
07/03/19 |
07/03/19 |
ASX - By Stock
|
101
|
42K
|
7
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4D, Half Year Accounts and Strategy Update
|
|
Ozjin
|
27 |
10K |
1 |
25/02/19 |
25/02/19 |
ASX - By Stock
|
27
|
10K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4D, Half Year Accounts and Strategy Update
|
|
Ozjin
|
27 |
10K |
2 |
25/02/19 |
25/02/19 |
ASX - By Stock
|
27
|
10K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4D, Half Year Accounts and Strategy Update
|
|
Ozjin
|
27 |
10K |
4 |
24/02/19 |
24/02/19 |
ASX - By Stock
|
27
|
10K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4D, Half Year Accounts and Strategy Update
|
|
Ozjin
|
27 |
10K |
7 |
22/02/19 |
22/02/19 |
ASX - By Stock
|
27
|
10K
|
7
|
|
ASX - By Stock
|
AN1 |
Re:
Comparisons, Connections & Conspiracy Theories
|
|
Ozjin
|
389 |
105K |
7 |
21/02/19 |
21/02/19 |
ASX - By Stock
|
389
|
105K
|
7
|
|
ASX - By Stock
|
AN1 |
Re:
CDY Half-Yearly Analyses
|
|
Ozjin
|
127 |
36K |
2 |
17/02/19 |
17/02/19 |
ASX - By Stock
|
127
|
36K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
CDY Half-Yearly Analyses
|
|
Ozjin
|
127 |
36K |
3 |
16/02/19 |
16/02/19 |
ASX - By Stock
|
127
|
36K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Significant New Findings Published on Midkine
|
|
Ozjin
|
29 |
17K |
1 |
07/02/19 |
07/02/19 |
ASX - By Stock
|
29
|
17K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Comparisons, Connections & Conspiracy Theories
|
|
Ozjin
|
389 |
105K |
1 |
27/01/19 |
27/01/19 |
ASX - By Stock
|
389
|
105K
|
1
|
|